Title: The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
Journal: Oncology reports 20120701
Title: [Long-term and high-dose bisphosphonate administration causes no bone over-mineralization].
Journal: Zhonghua yi xue za zhi 20091117
Title: Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis.
Journal: Anticancer research 20091101
Title: Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080901
Title: Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Journal: International journal of urology : official journal of the Japanese Urological Association 20080601
Title: Sugar synthesis from a gas-phase formose reaction.
Journal: Astrobiology 20070601
Title: Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
Journal: British journal of haematology 20070201
Title: Inhibition of bone resorption in cultures of mouse calvariae by apicularen A.
Journal: Planta medica 20070201
Title: Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells.
Journal: Anticancer research 20070101
Title: Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma.
Journal: International journal of hematology 20061101
Title: Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.
Journal: Cancer letters 20060618
Title: Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cells.
Journal: Anticancer research 20060101
Title: Effect of incadronate on proliferation of mesenchymal tumor cells with or without activated Ras mutation.
Journal: Journal of experimental & clinical cancer research : CR 20051201
Title: Nitrogen-containing bisphosphonate incadronate augments the inhibitory effect of farnesyl transferase inhibitor tipifarnib on the growth of fresh and cloned myeloma cells in vitro.
Journal: Leukemia & lymphoma 20051101
Title: Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma.
Journal: International journal of hematology 20051001
Title: Incadronate disodium inhibits joint destruction and periarticular bone loss only in the early phase of rat adjuvant-induced arthritis.
Journal: Journal of bone and mineral metabolism 20050101
Title: Effect of incadronate on corticosteroid-induced osteopenia in rats.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040901
Title: Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model.
Journal: Urological research 20040601
Title: Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.
Journal: Cellular signalling 20030701
Title: Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis.
Journal: The Journal of rheumatology 20030601
Title: [Changes of urinary deoxypyridinoline crosslink/creatinine in rats after ovariectomy and anti-osteoporotic intervention].
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20030601
Title: Incadronate amplifies prostaglandin F2 alpha-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity.
Journal: The Journal of biological chemistry 20030523
Title: Hydronium (cycloheptylammonio)methylene-1,1-bisphosphonate (hydronium incadronate).
Journal: Acta crystallographica. Section C, Crystal structure communications 20030201
Title: Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Journal: The Journal of urology 20030101
Title: Effects of bisphosphonate on bone reaction after placement of titanium implants in tibiae of ovariectomized rats.
Journal: The International journal of oral & maxillofacial implants 20030101
Title: Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.
Journal: Biochemical and biophysical research communications 20020920
Title: Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.
Journal: European journal of pharmacology 20020802
Title: Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate.
Journal: Japanese journal of pharmacology 20010501
Title: Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010301
Title: A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells.
Journal: Leukemia research 20010101
Title: [A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20000801
Title: The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Journal: Cancer research 19981201
Title: Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
Journal: International journal of clinical pharmacology and therapeutics 19970601
